These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 39075454)

  • 1. Efficacy and safety of transcutaneous auricular vagus nerve stimulation for frequent premature ventricular complexes: rationale and design of the TASC-V trial.
    Liu Y; Wei X; Wang L; Yang Y; Xu L; Sun T; Yang L; Cai S; Liu X; Qin Z; Bin L; Sun S; Lu Y; Cui J; Liu Z; Wu J
    BMC Complement Med Ther; 2024 Jul; 24(1):288. PubMed ID: 39075454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of transcutaneous auricular vagus nerve stimulation in patients with mild cognitive impairment: A double blinded randomized clinical trial.
    Wang L; Zhang J; Guo C; He J; Zhang S; Wang Y; Zhao Y; Li L; Wang J; Hou L; Li S; Wang Y; Hao L; Zhao Y; Wu M; Fang J; Rong P
    Brain Stimul; 2022; 15(6):1405-1414. PubMed ID: 36150665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of transcutaneous auricular vagus nerve stimulation on major depressive disorder: A nonrandomized controlled pilot study.
    Rong P; Liu J; Wang L; Liu R; Fang J; Zhao J; Zhao Y; Wang H; Vangel M; Sun S; Ben H; Park J; Li S; Meng H; Zhu B; Kong J
    J Affect Disord; 2016 May; 195():172-9. PubMed ID: 26896810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of transcutaneous auricular vagus nerve stimulation in the treatment of depressive disorder: A systematic review and meta-analysis of randomized controlled trials.
    Tan C; Qiao M; Ma Y; Luo Y; Fang J; Yang Y
    J Affect Disord; 2023 Sep; 337():37-49. PubMed ID: 37230264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcutaneous auricular vagus nerve stimulation to acutely reduce emotional vulnerability and improve emotional regulation in borderline personality disorder (tVNS-BPD): study protocol for a randomized, single-blind, sham-controlled trial.
    Guerriero G; Liljedahl SI; Carlsen HK; López Muñoz M; Daros AR; Ruocco AC; Steingrimsson S
    Trials; 2024 Jun; 25(1):397. PubMed ID: 38898522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcutaneous electrical vagus nerve stimulation to suppress premature ventricular complexes (TREAT PVC): study protocol for a multi-center, double-blind, randomized controlled trial.
    Cai C; Wu N; Yang G; Yang S; Liu W; Chen M; Po SS;
    Trials; 2023 Oct; 24(1):683. PubMed ID: 37872628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation vs Citalopram for Major Depressive Disorder: A Randomized Trial.
    Li S; Rong P; Wang Y; Jin G; Hou X; Li S; Xiao X; Zhou W; Wu Y; Liu Y; Zhang Y; Zhao B; Huang Y; Cao J; Chen H; Hodges S; Vangel M; Kong J
    Neuromodulation; 2022 Apr; 25(3):450-460. PubMed ID: 35088753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short trains of transcutaneous auricular vagus nerve stimulation (taVNS) have parameter-specific effects on heart rate.
    Badran BW; Mithoefer OJ; Summer CE; LaBate NT; Glusman CE; Badran AW; DeVries WH; Summers PM; Austelle CW; McTeague LM; Borckardt JJ; George MS
    Brain Stimul; 2018; 11(4):699-708. PubMed ID: 29716843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcutaneous auricular vagus nerve stimulation improves anxiety symptoms and cortical activity during verbal fluency task in Parkinson's disease with anxiety.
    Zhang H; Shan AD; Wan CH; Cao XY; Yuan YS; Ye SY; Gao MX; Gao LZ; Tong Q; Gan CT; Sun HM; Zhang KZ
    J Affect Disord; 2024 Sep; 361():556-563. PubMed ID: 38925314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcutaneous auricular vagus nerve stimulation for epilepsy.
    Zhang Q; Luo X; Wang XH; Li JY; Qiu H; Yang DD
    Seizure; 2024 Jul; 119():84-91. PubMed ID: 38820674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurophysiologic effects of transcutaneous auricular vagus nerve stimulation (taVNS) via electrical stimulation of the tragus: A concurrent taVNS/fMRI study and review.
    Badran BW; Dowdle LT; Mithoefer OJ; LaBate NT; Coatsworth J; Brown JC; DeVries WH; Austelle CW; McTeague LM; George MS
    Brain Stimul; 2018; 11(3):492-500. PubMed ID: 29361441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution computational modeling of the current flow in the outer ear during transcutaneous auricular Vagus Nerve Stimulation (taVNS).
    Kreisberg E; Esmaeilpour Z; Adair D; Khadka N; Datta A; Badran BW; Bremner JD; Bikson M
    Brain Stimul; 2021; 14(6):1419-1430. PubMed ID: 34517143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcutaneous auricular vagus nerve stimulation improves gait and cortical activity in Parkinson's disease: A pilot randomized study.
    Zhang H; Cao XY; Wang LN; Tong Q; Sun HM; Gan CT; Shan AD; Yuan YS; Zhang KZ
    CNS Neurosci Ther; 2023 Dec; 29(12):3889-3900. PubMed ID: 37311693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory Administration of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS): Technique, Targeting, and Considerations.
    Badran BW; Yu AB; Adair D; Mappin G; DeVries WH; Jenkins DD; George MS; Bikson M
    J Vis Exp; 2019 Jan; (143):. PubMed ID: 30663712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ear your heart: transcutaneous auricular vagus nerve stimulation on heart rate variability in healthy young participants.
    Forte G; Favieri F; Leemhuis E; De Martino ML; Giannini AM; De Gennaro L; Casagrande M; Pazzaglia M
    PeerJ; 2022; 10():e14447. PubMed ID: 36438582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcutaneous auricular vagus nerve stimulation at 1 Hz modulates locus coeruleus activity and resting state functional connectivity in patients with migraine: An fMRI study.
    Zhang Y; Liu J; Li H; Yan Z; Liu X; Cao J; Park J; Wilson G; Liu B; Kong J
    Neuroimage Clin; 2019; 24():101971. PubMed ID: 31648171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcutaneous auricular vagus nerve stimulation therapy in patients with cognitively preserved structural focal epilepsy: A case series report.
    Shiraishi H; Egawa K; Murakami K; Nakajima M; Ueda Y; Nakakubo S; Narugami M; Kimura S; Goto T; Hiramatsu Y; Murakami M
    Brain Dev; 2024 Jan; 46(1):49-56. PubMed ID: 37657962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor Activated Auricular Vagus Nerve Stimulation as a Potential Neuromodulation Approach for Post-Stroke Motor Rehabilitation: A Pilot Study.
    Badran BW; Peng X; Baker-Vogel B; Hutchison S; Finetto P; Rishe K; Fortune A; Kitchens E; O'Leary GH; Short A; Finetto C; Woodbury ML; Kautz S
    Neurorehabil Neural Repair; 2023 Jun; 37(6):374-383. PubMed ID: 37209010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcutaneous auricular vagus nerve stimulation would be an alternative to implantable cervical vagus nerve stimulation in some situation.
    Jiakai HE; Jinling Z; Yu W; Shaoyuan LI; Jiliang F; Shuai Z; Yanan Z; Weihang Z; Deqiang G; Ran LI; Yuhang J; Zehao C; Baohui J; Peijing R
    J Tradit Chin Med; 2023 Jun; 43(3):627-630. PubMed ID: 37147767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of transcutaneous auricular vagus nerve stimulation on impaired glucose tolerance: a pilot randomized study.
    Huang F; Dong J; Kong J; Wang H; Meng H; Spaeth RB; Camhi S; Liao X; Li X; Zhai X; Li S; Zhu B; Rong P
    BMC Complement Altern Med; 2014 Jun; 14():203. PubMed ID: 24968966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.